{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE300nnn/GSE300515/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Other"],"species":["synthetic construct"," Mus musculus"],"gds_type":["Other"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300515"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"The Nonamer Code for RAG1-mediated Recombination in vivo","description":"V(D)J recombination, essential for adaptive immunity, is initiated by RAG1/2, which recognizes Recombination Signal Sequences (RSSs) flanking gene segments at Antigen Receptor (AgR) loci. RSSs comprise conserved heptamer and nonamer motifs separated by a 12/23-base spacer. While the first three heptamer nucleotides (5’-CAC) are strictly conserved, RSS promiscuity enables RAG “off-target” activity at RSS-like sequences, termed “cryptic RSSs” (cRSSs), contributing to chromosomal deletions and lymphoid tumorigenesis. Notably, the nonamer exhibits substantial sequence variability across physiological RSSs. In addition, many cRSSs lack a discernible nonamer-like sequence, limiting the ability to predict RAG targets based on RSS consensus. Using a high-throughput approach, we characterized here the nonamer properties supporting RAG-mediated recombination. While the consensus nonamer (5’-ACAAAAACC) exhibited strong functionality, numerous sequences significantly diverged from it promoted high recombination rate. These functional nonamers balance two, somewhat opposing, features: affinity for the RAG nonamer-binding domain (NBD) – primarily via a shared purine–weak–purine (RWR) motif at positions 4–6, and nucleosome repulsion. Moreover, nonamers of genomic cRSSs mimic canonical nonamers mainly through nucleosome-repelling sequences. This study provides a model for both physiological RAG activity and its off-target effects, enhancing our understanding of immune repertoire formation and the genetic basis of lymphoid cancers.","dates":{"publication":"2025/12/30"},"accession":"GSE300515","cross_references":{"GSM":["GSM9063716","GSM9063718","GSM9063717"],"GPL":["17769","16417"],"GSE":["300515"],"taxon":["synthetic construct"," Mus musculus"],"PMID":["[41408651]"]}}